Creative Diagnostics
Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs).
More Information
Supplier Page
Creative Diagnostics
Creative Diagnostics
Creative Diagnostics
Peposertib is an orally bioavailable inhibitor of DNA-dependent protein kinase (DNA-PK) with potential antineoplastic activity, and potential sensitizing and enhancing activities for both chemo- and radiotherapies. Upon administration, peposertib binds to and inhibits the activity of DNA-PK, thereby interfering with the non-homologous end joining (NHEJ) process and preventing repair of DNA double strand breaks (DSBs) […]
More Information
Supplier Page
Creative Diagnostics
C15H17ClN4; CAS Number: 88671-89-0.Myclobutanil is a light yellow solid used as a fungicide. It is a triazole chemical used as a fungicide. It is a steroid demethylation inhibitor, specifically inhibiting ergosterol biosynthesis.
More Information
Supplier Page
Creative Diagnostics
C15H17ClN4; CAS Number: 88671-89-0.Myclobutanil is a light yellow solid used as a fungicide. It is a triazole chemical used as a fungicide. It is a steroid demethylation inhibitor, specifically inhibiting ergosterol biosynthesis.
More Information
Supplier Page
Creative Diagnostics
C14H22NO4PS; Isofenphos-methyl is a broad spectrum, organophosphorus insecticide, used to control soil pests in grain and oil crops such as click beetles, mole cricket and grub.
More Information
Supplier Page
Creative Diagnostics
Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs).
More Information
Supplier Page
Creative Diagnostics
Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs).
More Information
Supplier Page
Creative Diagnostics
Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of the approved drug belantamab mafodotin in multiple myeloma and some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody.
More Information
Supplier Page